Sign in

Noah markewitz

@noahmarkewitz11.bsky.social
76 followers 625 following 14 posts

Internal Medicine Resident at Montefiore. Interested in Med Ed and Nephrology He/him

PostsRepliesMedia
Noah markewitz @noahmarkewitz11.bsky.social · 05/10/2026
Really liked this breakdown of the STAREE trial. open.spotify.com/episode/3waO...
open.spotify.com
STAREE Trial : Statins after Seventy?
Heartline: The Cardio Trials Podcast · Episode
000
Noah markewitz @noahmarkewitz11.bsky.social · 28/07/2026
Wild to think that 5 years ago everyone told me not to do nephrology because “there are no new treatments for kidney disease” and now here I am a brand new July nephrology fellow filling out my first form requesting approval for Sibeprenlimab for IgA Nephropathy in GN clinic today!
000
Noah markewitz @noahmarkewitz11.bsky.social · 14/05/2026
Spent last night at the montefiore research symposium discussing some palliative nephrology!
010
Reposted by Noah markewitz
NephMadness @nephmadness.bsky.social · 26/03/2026
Listen to this special #NephMadness episode of @coreimpodcast.bsky.social to hear @shreyatrivedimd.bsky.social, @noahmarkewitz11.bsky.social , and @jrkott27.bsky.social discuss all things POCUS: www.coreimpodcast.com/2026/03/23/p...
coreimpodcast.com
POCUS for AKI & Dialysis | Real Cases That Changed Management – Core IM Podcast
155
Noah markewitz @noahmarkewitz11.bsky.social · 06/03/2026
A fantastic discussion on what it really means to tell a patient they have high risk APOL1 alleles, and if we are benefiting them by doing so. open.spotify.com/episode/1HBJ...
open.spotify.com
Spotify – Web Player
000
Reposted by Noah markewitz
Lars Mølgaard Saxhaug @load-dependent.eurosky.social · 17/11/2025
Reharing my #shiny leaf plot app, demonstrating the relationship between prevalence/pre-test probability, sensitivity, specificity and post-test probabilities. lmsaxhaug.shinyapps.io/Leaf_App/ #rstats #meded #emimcc #cardiosky #medsky
Screenshot from shiny web app where you can select sensitivity and speicifity and produce a plot resembling a leaf which shows post-test probability as a function of a negative or positive test and pre-test probability.
1114
Reposted by Noah markewitz
CORE IM @coreimpodcast.bsky.social · 19/11/2025
1/ 🚨 NEW episode on venous congestion & the VExUS score 💧 Venous congestion is a century-old concept, but modern tools now allow clinicians to detect, quantify, and monitor it ‼️ 🖥️: www.coreimpodcast.com/2025/11/19/v...
141
Noah markewitz @noahmarkewitz11.bsky.social · 17/11/2025
The way to get younger doctors back to the bedside is with data the physical exam finding outperforms other care. This is exactly what the ANDROMEDA shock 1 and 2 trial has done for capillary refill time. This is also the reason POCUS has brought younger docs back to the bedside!
000
Noah markewitz @noahmarkewitz11.bsky.social · 08/11/2025
A positive trial in cardiac prevention for HD patients, how cool is this!
020
Noah markewitz @noahmarkewitz11.bsky.social · 08/11/2025
Such a cool study and further evidence on the funny and sad truth that hemodynamic shifts of dialysis actually worsen renal recovery jamanetwork.com/journals/jam...
jamanetwork.com
A Conservative Dialysis Strategy and Kidney Function Recovery in Dialysis-Requiring Acute Kidney Injury
This trial examines whether a conservative dialysis strategy can improve recovery of kidney function for patients with acute kidney injury who require dialysis.
010
Noah markewitz @noahmarkewitz11.bsky.social · 30/10/2025
Love a well made sequel! But 10 percent absolute mortality decrease might have been asking for too much? Also why bicarb vs. no bicarb and not bicarb vs placebo? Have to wonder if no bicarb group received dialysis early because everyone knew they weren’t getting bicarb.
000
Noah markewitz @noahmarkewitz11.bsky.social · 22/10/2025
Had so much to say about HRS we had to split it into two episodes! Check out part 2 on HRS treatment, Transplant, and a topic near and dear to my heart, palliative care.
032
Reposted by Noah markewitz
Antibiotic Steward 🅱️C🆔🅿️🌟 @absteward.bsky.social · 19/10/2025
🆕🔥🔥CloCeBa RCT Cloxacillin versus cefazolin for MSSA Bacteraemia Cefazolin has a non-inferior efficacy regarding mortality, microbiological or clinical endpoints and was associated with a lower rate of serious adverse events #IDSky www.thelancet.com/journals/lan...
04016
Noah markewitz @noahmarkewitz11.bsky.social · 15/10/2025
It has been a dream to be able to be a part of my favorite podcast. Check out this very fun episode on one of the most interesting diseases, Hepatorenal Syndrome!
042
Noah markewitz @noahmarkewitz11.bsky.social · 14/10/2025
Excited to share a new case report from my time in the CCU… we present a multidisciplinary management of a RCA STEMI complicated by cardiogenic shock, severe mitral regurgitation, and complete heart block. www.jacc.org/doi/abs/10.1...
jacc.org
Multidisciplinary Management and Hemodynamic Rescue of Cardiogenic Shock in RCA STEMI With Severe Mitral Regurgitation:
000
Noah markewitz @noahmarkewitz11.bsky.social · 03/09/2025
“Nothing is so privileged as thinking history belongs to the past.”- John Green. Everything is Tuberculosis
010
Noah markewitz @noahmarkewitz11.bsky.social · 29/08/2025
Found a nephrology textbook from 1859 at a bookstore. Even back then nephrologists loved saying there’s no such thing as normal urine labs, only normal serum labs.
000
Noah markewitz @noahmarkewitz11.bsky.social · 17/08/2025
Love this change in the new 2025 AHA HTN guidelines. Hypertensive urgency completely removed. Asymptomatic severe HTN as outpatient , DO NOT send to the emergency room, and more importantly if in the ED, NOT to give IV meds, nor admit. Much needed evidence based change.
000